Evidence map›Paper›PMID 23295933›Full record

ArticleAntimicrobial agents and chemotherapy2013

High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Hui Wang, Chunjiang Zhao, Wenqiang He, Feifei Zhang, Liyan Zhang, Bin Cao, Ziyong Sun, Yingchun Xu, Qing Yang, Yaning Mei and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Genomic characterization of group BMicrobial genomics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Invasive group B streptococcal infection in infants in Shenzhen, China.International journal of clinical and experimental medicine · 2015
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 1 country.

Hui WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Chunjiang Zhao
Wenqiang He
Feifei Zhang
Liyan Zhang
Bin Cao
Ziyong Sun
Yingchun Xu
Qing Yang
Yaning Mei
Bijie Hu
Yunzhuo Chu
Kang Liao
Yunsong Yu
Zhidong Hu
Yuxing Ni
Peking University · CNCapital Medical University · CNChina Medical University · CNFirst Affiliated Hospital Zhejiang University · CNGuangdong General Hospital · CNNanjing General Hospital of Nanjing Military Command · CNPeking Union Medical College Hospital · CNPeking University People's Hospital · CNRuijin Hospital · CNSir Run Run Shaw Hospital · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNTianjin Medical University · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 146 group B streptococcus isolates from 8 cities across China belonged to four serotypes. Serotype Ia was more common in children. A high prevalence of resistance was observed for levofloxacin (37.7%), erythromycin (71.2%), clindamycin, (53.4%), and tetracycline (81.5%). The levofloxacin and clindamycin resistances among the 4 serotypes differed significantly. Eighty percent of fluoroquinolone-resistant isolates belonged to the sequence type 19 (ST19)/serotype III clone, with GyrA-ParC-ParE triple substitutions. This clone carried the erm(B), mef(E), and tet(M) genes.

Indexed as

Genes, BacterialLevofloxacinAdolescentAdultAgedAnti-Bacterial AgentsChinaClindamycinDNA GyraseDNA Topoisomerase IVDrug Resistance, BacterialErythromycinHumansMiddle AgedMutationOfloxacinAnti-Bacterial AgentsClindamycinDNA GyraseDNA Topoisomerase IVErythromycinLevofloxacinOfloxacinTetracycline

Identifiers

PMID23295933
PMCPMC3591929
OpenAlexW2148957762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.